dorsaVi

dorsaVi R&D / Revenue

The R&D to Revenue Ratio of dorsaVi (DVL.AX) as of Nov 5, 2026 is 171.83 %. In the previous year, R&D to Revenue Ratio was 81.07 % — a change of 111.96% (higher).

R&D / Revenue

171.83 %

YoY

111.96%

Last updated:

R&D to Revenue Ratio of dorsaVi is 2026 171.83 % . R&D to Revenue Ratio of dorsaVi was 2025 81.07 % . It decreases by 111.96% higher compared to the previous year.

The dorsaVi R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2019
80.96 AUD
Jan 1, 2020
52.07 AUD
Jan 1, 2021
51.39 AUD
Jan 1, 2022
54.93 AUD
Jan 1, 2023
65.50 AUD
Jan 1, 2024
80.47 AUD
Jan 1, 2025
81.07 AUD
Jan 1, 2026
171.83 AUD
The dorsaVi R&D / Revenue history
YEARR&D / RevenueYoY
171.83 %+111.96%
81.07 %+0.75%
80.47 %+22.86%
65.50 %+19.24%
54.93 %+6.88%
51.39 %-1.30%
52.07 %-35.69%
80.96 %+5.64%
76.64 %+43.91%
53.26 %+6.67%
49.93 %-52.95%
106.11 %-54.83%
234.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

dorsaVi Stock analysis

What does dorsaVi do? The company dorsaVi Ltd is a leading company in the field of wearable technology based in Australia. The company was founded in 2000 by Andrew Ronchi, Andrew Dalziel, and Daniel Dorsch with the vision to improve people's health through the development of technologies that can measure human movement and performance. dorsaVi's business model is based on the development and marketing of wearable technology for use in medicine, rehabilitation, and sports. The company aims to develop innovative, user-friendly, and reliable devices that help users optimize their movement and performance. The products are used by professional athletes, physiotherapists, trainers, and doctors worldwide. dorsaVi's mission is to improve the health and well-being of people and prevent injuries by providing accurate and easy-to-use solutions. The company is built on three main pillars: Sports, Clinical, and Occupational. Each of these pillars has specific products and solutions to help users in different industries and application areas. In the Sports field, dorsaVi offers a wide range of products and solutions for professional athletes and trainers to optimize their performance and prevent injuries. The company's flagship product is the ViPerform system. This system allows athletes to accurately analyze and improve their movements during training or competition. It consists of wireless sensors attached to various parts of the body to capture data on movements, speed, acceleration, and force. The data is then sent to the dorsaVi app in real-time, where it can be analyzed, visualized, and interpreted. In the Clinical field, dorsaVi provides solutions for therapists and doctors to support patients in their recovery after an injury or surgery. The Sentral Clinical Movement Analysis System offered in this field is an advanced system for analyzing human movement. It allows therapists to observe and analyze movement patterns accurately to identify disruptions and weaknesses that may lead to pain or injuries. The collected data can help create individual therapy plans and accelerate recovery. In the Occupational field, dorsaVi develops solutions for companies and employees to improve their health and safety in the workplace. This includes the Sentral Wearable Movement Monitoring System. The system is a wireless and non-invasive solution that allows employers and employees to record and analyze their movement and load profiles in real-time. The collected data can help make ergonomic adjustments in the workplace to prevent injuries and illnesses. Over the years, dorsaVi has received numerous awards for its products and solutions. However, the company continues to strive to develop innovative technologies and products to help people optimize their movement and performance, increase their well-being, and maintain their long-term health. dorsaVi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about dorsaVi stock

R&D to Revenue Ratio of dorsaVi is 171.83 % in 2026.

R&D to Revenue Ratio of dorsaVi changed from 81.07 % to 171.83 %, representing a 111.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio dorsaVi since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's dorsaVi with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — dorsaVi

All Key Metrics — dorsaVi